Search results for "Ophthalmologists"

showing 3 items of 3 documents

What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects

2020

Within the COVID-19 pandemic context, the WHO has proposed a list of medicines to treat patients with severe acute respiratory syndrome (SARS-CoV-2). An analysis of their ocular side effects was performed. Only chloroquine and hydroxychloroquine were found to have an ocular impact in the medium and long-term. Detailed search strategies were performed in EMBASE, MEDLINE, SCOPUS and WOS Core Collection. Additionally, the worldwide ongoing clinical trials including chloroquine or hydroxychloroquine were evaluated, and their proposals of drug administration and exclusion criteria analyzed. In general, high maximum cumulative doses of chloroquine or hydroxychloroquine are being used for a short…

0301 basic medicinemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsCoronavirus disease 2019 (COVID-19)Health PersonnelRetinal pathology / researchSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Context (language use)medicine.disease_causeRetinaAntimalarials03 medical and health sciences0302 clinical medicineRetinal DiseasesChloroquineInternal medicinePandemicmedicineHumansRETINARetina – medical therapiesCoronavirusPharmacologyOphthalmologistsSARS-CoV-2business.industryCOVID-19ChloroquineHydroxychloroquineGeneral MedicineSystemic drug retinal ToxicityTechniques of retinal examinationCOVID-19 Drug TreatmentCoronavirusClinical trialOphthalmology030104 developmental biologyCaregiversMedicina Preventiva y Salud Pública030221 ophthalmology & optometryHuman medicinebusinessHydroxychloroquinemedicine.drugEuropean journal of ophthalmology
researchProduct

Can ‘Fellow of the European Board of Ophthalmology Subspecialty Diploma in Glaucoma,’ a subspecialty examination on glaucoma induce the qualification…

2016

From 2015, the examination of Fellow of the European Board of Ophthalmology Subspecialty Diploma in Glaucoma (FEBOS-Glaucoma) was launched by the European Board of Ophthalmology (EBO) in cooperation with the European Glaucoma Society (EGS). This opinion aims at disclosing the background of the examination, prerequisite to the examination, and the value of the FEBOS-Glaucoma diploma.

Organes des sensgenetic structures020205 medical informaticsSpecialty boardophtalmologielcsh:MedicineGlaucoma02 engineering and technology0302 clinical medicineSpecialty Boards0202 electrical engineering electronic engineering information engineeringPractice Patterns Physicians'ComputingMilieux_MISCELLANEOUSSocieties Medicallcsh:LC8-6691Ophthalmologists3. Good healthClinical PracticeEurope[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansGeneral Health ProfessionsClinical CompetenceCurriculumClinical competenceSpecializationEducational measurementmedicine.medical_specialtyOpinionSensory OrganseducationMédecine humaine et pathologieSubspecialtyEducation03 medical and health sciencesOphthalmologymedicineHumans[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansFellowships and Scholarshipslcsh:Special aspects of educationbusiness.industrylcsh:RInternship and ResidencyGlaucomamedicine.diseaseeye diseasesOphthalmologyEducation Medical Graduate030221 ophthalmology & optometryOptometryHuman health and pathologysense organsEducational MeasurementbusinessJournal of Educational Evaluation for Health Professions
researchProduct

The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases.

2020

Purpose: To assess the usefulness of a dedicated questionnaire for patients with inflammatory bowel diseases (IBD) treated with biological drugs for the detection of ocular extraintestinal manifestations (EIMs). IBD can cause extraintestinal symptoms including ocular complaints which are frequently ignored and may be associated with significant morbidity, including blindness. Methods: We developed a questionnaire, named Ocular Manifestations in IBD Screening (OMIS) questionnaire, after agreement between gastroenterologists and ophthalmologists. The questionnaire was administered by a non-ophthalmologist physician to 96 IBD patients treated with biological drugs. Results: 35 patients (36.5%)…

Clinical teammedicine.medical_specialtygenetic structuresScreening testPilot ProjectsInflammatory bowel diseaseBiological drugsQuality of lifeInternal medicineSurveys and QuestionnairesmedicineHumansBlindnessBiologic drugs Inflammatory bowel disease Ocular extraintestinal manifestation QuestionnaireOphthalmologistsbusiness.industrySettore MED/30 - Malattie Apparato VisivoInflammatory Bowel Diseasesmedicine.diseaseInflammatory Bowel Diseasesdigestive system diseaseseye diseasesOphthalmologyOphthalmologic examinationQuality of LifebusinessInternational ophthalmology
researchProduct